ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,459, issued on Oct. 21, was assigned to GENMAB HOLDING B.V. (Utrecht, Netherlands).
"Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof" was invented by Simone Oostindie (Utrecht, Netherlands), Frank Beurskens (Utrecht, Netherlands), Esther Breij (Utrecht, Netherlands), Edward Van Den Brink (Utrecht, Netherlands), Andreas Hollenstein (Utrecht, Netherlands), Marije Overdijk (Utrecht, Netherlands), Margaret Lindorfer (Keswick, Va.), Ronald Taylor (Keswick, Va.), Paul Parren (Odijk, Netherlands), Hilma Van Der Horst (Utrecht, Netherlands), Martine E. D. Chamuleau (Amsterdam) and Tuna Mutis (Amsterdam).
According to the abstract* released by t...